Come on, you can do better than that
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Additionally, aromatase (CYP19A1) is expressed by breast adipose stromal cells and cancer-associated fibroblasts, which plays a crucial role in oestrogen production both locally and systemically, particularly in women who undergo through menopause (186)
Administration Injection type: Intramuscular (IM) or subcutaneous IM injection sites: Deltoid (upper arm), gluteus (buttock), or vastus lateralis (outer thigh) Subcutaneous sites: Abdomen, outer thigh, or back of upper arm Needle gauge: 25-27 gauge for IM, insulin syringe for subcutaneous Timing: Morning or early afternoon is preferred, as the energy boost may interfere with sleep if taken late in the day
Weight loss of 515% is recommended to improve many of the complications of overweight/obesity, with greater improvements observed with further weight reductions [5, 9]
[4] [2] Clinical trials have demonstrated substantial reductions in hemoglobin A1c (up to 2.5%) and body weight (approximately 15-22.5% depending on dose in the SURMOUNT-1 trial), making it a significant advancement in metabolic disease treatment